Try our Advanced Search for more refined results

FTC Challenges Illumina's $1B DNA Sequencing Buy

By Bryan Koenig (December 17, 2019, 5:04 PM EST) -- The Federal Trade Commission launched a merger challenge Tuesday accusing Illumina of trying to "unlawfully maintain" a monopoly over next-generation DNA sequencing systems in the U.S., saying the company is seeking to eliminate "a nascent competitive threat" through its proposed $1.2 billion purchase of Pacific Biosciences....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!